Leaflet RISEDRONAT SODIC HF 35mg film-coated tablets
Indicated for: osteoporosis
Route of administration: oral
Substance: risedronic acid (bisphosphonate)
ATC: M05BA07 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates)
Take this medicine on an empty stomach.
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Risedronic acid is a bisphosphonate used for the prevention and treatment of osteoporosis, particularly in postmenopausal women. It is also used to treat Paget's disease of the bone.
It works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption, leading to increased bone density and reduced risk of fractures. It is taken orally, usually once a week or once a month, depending on the indication.
Common side effects include gastrointestinal disturbances such as nausea, abdominal pain, and heartburn. In rare cases, it may cause osteonecrosis of the jaw or atypical femur fractures.
Patients taking risedronic acid should follow administration instructions, such as taking the medication on an empty stomach and avoiding lying down for 30 minutes after taking it, to reduce the risk of esophageal irritation.
General data about RISEDRONAT SODIC HF 35mg
- Substance: risedronic acid
- Date of latest medicines list: 01-07-2013
- Product code: W55087001
- Concentration: 35mg
- Pharmaceutical form: film-coated tablets
- Quantity: 4
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for risedronic acid
Concentrations available for risedronic acid
- 30mg
- 35mg
- 5mg
- 75mg